Small Left Ventricular Chamber Size and Mortality in a Large General Population

David Leibowitz1, Donna Zwas1, Offer Amir1

  • 1Heart Institute, Hadassah Medical Center and Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel.

PubMed

Insights

A small left ventricle (LV) chamber size, previously unstudied in the general population, is linked to increased mortality risk. This finding holds true across all age groups and sexes, highlighting a new cardiovascular risk factor.

Area of Science:

  • Cardiology
  • Echocardiography
  • Public Health

Background:

  • Left ventricular (LV) enlargement signifies adverse cardiac remodeling and poor prognosis.
  • Previous research indicated cardiovascular risk in small patient subsets with small LV chamber size.
  • The prognostic impact of small LV chamber size in the general population remained largely unexamined.

Purpose of the Study:

  • To investigate the association between small left ventricular (LV) chamber size and all-cause mortality in a large, general population cohort.
  • To determine if small LV chamber size is an independent predictor of mortality across diverse demographic groups.

Main Methods:

  • Retrospective analysis of 46,529 subjects undergoing echocardiography between 2011 and 2023.
  • Small LV chamber size defined by American Society of Echocardiography guidelines (end-diastolic diameter <42 mm for men, <37.8 mm for women).
  • Multivariable analysis assessed the association between small LV size and all-cause mortality, adjusting for clinical and echocardiographic variables.

Main Results:

  • A small LV chamber size was identified in 3,787 subjects and was associated with older age and lower body surface area.
  • Higher relative wall thickness and E/e' ratio were observed in subjects with small LV chambers.
  • Small LV chamber size significantly predicted all-cause mortality (HR 1.34, 95% CI 1.22-1.46, p <0.001) in multivariable analysis, irrespective of age or sex.

Conclusions:

  • Small left ventricular (LV) chamber size is a significant, independent predictor of all-cause mortality in a broad patient population.
  • The association between small LV size and mortality was consistent across younger and older individuals, as well as men and women.
  • Further research is warranted to understand the underlying mechanisms and develop targeted preventive strategies for individuals with small LV chambers.

Related Concept Videos

Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
2
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
4
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
1.3K
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1